Research Centre for Integrative Physiology and Pharmacology and Centre for Population Health Research, Institute of Biomedicine, University of Turku, Turku 20520, Finland.
Department of Pediatrics, Turku University Hospital, Turku 20520, Finland.
J Clin Endocrinol Metab. 2022 Nov 25;107(12):3353-3361. doi: 10.1210/clinem/dgac520.
Longitudinal data on levels of hypothalamic-pituitary-gonadal axis hormones and insulin-like growth factor I (IGF-I) during puberty in boys with a history of cryptorchidism are largely missing.
We aimed to compare pubertal hormone levels between boys with a history of congenital cryptorchidism who experienced spontaneous testicular descent or underwent orchiopexy and boys without a history of cryptorchidism.
This was a nested case-control study within a population-based birth cohort, with a prospective, longitudinal pubertal follow-up every 6 months (2005 to 2019). Participants were 109 Finnish boys, including boys with a history of unilateral cryptorchidism who underwent orchiopexy (n = 15), unilateral cryptorchidism who had spontaneous testicular descent (n = 15), bilateral cryptorchidism who underwent orchiopexy (n = 9), bilateral cryptorchidism who had spontaneous testicular descent (n = 7), and controls (n = 63). Serum reproductive hormone levels and testicular volumes were measured.
From around onset of puberty, boys with bilateral cryptorchidism who underwent orchiopexy had significantly higher follicle-stimulating hormone (FSH) and lower inhibin B levels than controls. Boys with unilateral cryptorchidism who underwent orchiopexy had significantly higher FSH than controls, whereas inhibin B levels were similar. Testosterone, luteinizing hormone, insulin-like factor 3, and IGF-I were generally similar between groups. Testicular volume of boys with unilateral or bilateral cryptorchidism who underwent orchiopexy was smaller than that of the controls from 1 year after pubertal onset (P < 0.05).
Cryptorchid boys, particularly those with bilateral cryptorchidism who underwent orchiopexy, had altered levels of serum biomarkers of Sertoli cells and germ cells and smaller testicular volumes compared with controls.
关于患有隐睾症的男孩在青春期期间的下丘脑-垂体-性腺轴激素和胰岛素样生长因子 I(IGF-I)水平的纵向数据在很大程度上是缺失的。
我们旨在比较有先天性隐睾症病史且经历了自发性睾丸下降或接受了睾丸固定术的男孩与没有隐睾症病史的男孩之间的青春期激素水平。
这是一项基于人群的出生队列内的嵌套病例对照研究,具有前瞻性、纵向的青春期随访,每 6 个月进行一次(2005 年至 2019 年)。参与者包括 109 名芬兰男孩,其中有单侧隐睾症病史且接受了睾丸固定术的男孩(n=15)、单侧隐睾症且自发性睾丸下降的男孩(n=15)、双侧隐睾症且接受了睾丸固定术的男孩(n=9)、双侧隐睾症且自发性睾丸下降的男孩(n=7)和对照组(n=63)。测量了血清生殖激素水平和睾丸体积。
从青春期开始左右,接受了睾丸固定术的双侧隐睾症男孩的卵泡刺激素(FSH)水平显著升高,而抑制素 B 水平显著降低,与对照组相比。接受了睾丸固定术的单侧隐睾症男孩的 FSH 水平显著高于对照组,而抑制素 B 水平相似。睾酮、黄体生成素、胰岛素样因子 3 和 IGF-I 通常在各组之间相似。接受了单侧或双侧隐睾症睾丸固定术的男孩的睾丸体积从青春期开始后 1 年起就小于对照组(P<0.05)。
与对照组相比,隐睾症男孩,特别是接受了睾丸固定术的双侧隐睾症男孩,其血清 Sertoli 细胞和生殖细胞生物标志物水平发生改变,睾丸体积较小。